Capitol Hill Briefs: Device Tax Repeal; Clinical Trials; DME Bidding
This article was originally published in The Gray Sheet
Executive Summary
Legislation introduced in the new Republican-controlled Senate include device tax repeal, a measure that would allow Medicaid recipients to enroll in clinical trials and a bill, introduced in parallel in the House, aimed at stopping non-binding bids for supplying durable medical equipment, prosthetics, orthotics and supplies.
You may also be interested in...
Industry Looking To New GOP Congress To Repeal Device Tax
AdvaMed says a new Congressional Research Service report underestimates the number of people likely to lose their jobs because of the tax and is looking forward to a new Republican Congress focused on repealing it.
News Briefs: Panel OKs Sleep Apnea Stimulator; Two Stryker Buys; TAVR Updates
FDA panel unanimously endorses Inspire upper airway stimulator. Stryker buys Berchtold and Pivot. First randomized U.S. study of embolic protection during transcatheter aortic valve replacement approved. More news.
Veru Hopes To Position Enobosarm As Muscle-Protective In Weight-Loss Therapy
A selective androgen receptor modulator also being studied in metastatic breast cancer, enobosarm might offer potential as add-on therapy to GLP-1 agonists prescribed for weight loss, the Miami biotech asserts.